Literature DB >> 3700625

Serodiagnosis of La Crosse virus infections in humans by detection of immunoglobulin M class antibodies.

C H Calisher, C I Pretzman, D J Muth, M A Parsons, E D Peterson.   

Abstract

Sera from 92 humans with illnesses clinically compatible with those caused by California serogroup virus infections were tested for antibody to La Crosse (LAC) virus by using the immunoglobulin M (IgM) antibody-capture enzyme-linked immunosorbent assay (MAC ELISA), the IgG ELISA, and the hemagglutination inhibition (HI), complement fixation and serum dilution-plaque reduction neutralization tests. On the reported day of onset of illness in 18 individuals, 94% had IgM antibody, 50% had neutralization antibody, 33% had HI antibody, and 11% had IgG antibody. Neutralization, HI, and IgG antibody prevalence rates increased thereafter, whereas IgM antibody prevalence remained high (92% 2 or more weeks after the onset of illness). It was concluded that the MAC ELISA is a sensitive test for the presence of antibody to LAC virus. The sensitivity of the MAC ELISA and the rapidity with which it can be performed appear to provide a powerful tool for the clinically relevant serodiagnosis of LAC virus infections in humans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700625      PMCID: PMC362813          DOI: 10.1128/jcm.23.4.667-671.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses.

Authors:  C H Calisher; A O el-Kafrawi; M I Al-Deen Mahmud; A P Travassos da Rosa; C R Bartz; M Brummer-Korvenkontio; S Haksohusodo; W Suharyono
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

2.  Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures.

Authors:  W A Chappell; P E Halonen; R F Toole; C H Calisher; L Chester
Journal:  Appl Microbiol       Date:  1969-09

3.  Jamestown Canyon virus: the etiologic agent of an emerging human disease?

Authors:  R Deibel; S Srihongse; M A Grayson; P R Grimstad; M S Mahdy; H Artsob; C H Calisher
Journal:  Prog Clin Biol Res       Date:  1983

4.  Clinical aspects of La Crosse encephalitis: preliminary report.

Authors:  C B Gundersen; K L Brown
Journal:  Prog Clin Biol Res       Date:  1983

5.  Neurologic aspects and treatment of La Crosse encephalitis.

Authors:  W M Deering
Journal:  Prog Clin Biol Res       Date:  1983

6.  California group virus encephalitis in three children from Quebec: clinical and serologic findings.

Authors:  M Fauvel; H Artsob; C H Calisher; L Davignon; A Chagnon; R Skvorc-Ranko; S Belloncik
Journal:  Can Med Assoc J       Date:  1980-01-12       Impact factor: 8.262

7.  Genotypic varieties of La Crosse virus isolated from different geographic regions of the continental United States and evidence for a naturally occurring intertypic recombinant La Crosse virus.

Authors:  R A Klimas; W H Thompson; C H Calisher; G G Clark; P R Grimstad; D H Bishop
Journal:  Am J Epidemiol       Date:  1981-07       Impact factor: 4.897

8.  Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis.

Authors:  T P Monath; R R Nystrom; R E Bailey; C H Calisher; D J Muth
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

9.  Rapid diagnosis of La Crosse virus infections: evaluation of serologic and antigen detection techniques for the clinically relevant diagnosis of La Crosse encephalitis.

Authors:  B J Beaty; T L Jamnback; S W Hildreth; K L Brown
Journal:  Prog Clin Biol Res       Date:  1983

10.  Serodiagnosis of La Crosse virus infections in humans.

Authors:  C H Calisher; R E Bailey
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

View more
  7 in total

1.  Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay.

Authors:  A J Johnson; D A Martin; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.

Authors:  D A Martin; D A Muth; T Brown; A J Johnson; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

3.  Are North American Bunyamwera serogroup viruses etiologic agents of human congenital defects of the central nervous system?

Authors:  C H Calisher; J L Sever
Journal:  Emerg Infect Dis       Date:  1995 Oct-Dec       Impact factor: 6.883

4.  Production and use of a hemagglutinin for detecting antibody to Jamestown Canyon virus.

Authors:  P R Grimstad; H Artsob; N Karabatsos; C H Calisher
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid.

Authors:  A Scott Muerhoff; George J Dawson; Bruce Dille; Robin Gutierrez; Thomas P Leary; Malini C Gupta; Charles R Kyrk; Hema Kapoor; Patricia Clark; Gerald Schochetman; Suresh M Desai
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

Review 6.  Medically important arboviruses of the United States and Canada.

Authors:  C H Calisher
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

7.  A duplex real-time reverse transcriptase polymerase chain reaction assay for the detection of California serogroup and Cache Valley viruses.

Authors:  Heng Wang; Seela Nattanmai; Laura D Kramer; Kristen A Bernard; Norma P Tavakoli
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10       Impact factor: 2.803

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.